Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE3A antisense RNA 1 (PDE3A-AS1) is a long non-coding RNA gene located near the protein-coding PDE3A gene. As an antisense transcript, it is thought to play a role in regulating the expression of PDE3A or nearby genes through RNA-based mechanisms such as transcriptional interference or post-transcriptional regulation. However, its molecular function, biological significance, and clinical relevance are not well-defined. It is not considered a druggable therapeutic target, and its role in human disease, if any, is currently unclear[3]. Note: If your intention was the protein-coding gene PDE3A—which is a well-established therapeutic target in cardiovascular disease, platelet aggregation, etc.—please specify, as "PDE3A-AS1" references a distinct, non-coding RNA with little evidence for its consideration as a therapeutic target[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE3A antisense RNA 1 (PDE3A-AS1).